Functional cloning of Vibrio parahaemolyticus type III secretion system 1 in Escherichia coli K-12 strain as a molecular syringe

Biochemical and Biophysical Research Communications

Volumn 427, Issue 2, 2012, Pages 242-247

  Akeda, Yukihiro ^a   Kimura, Tomomi ^a   Yamasaki, Aiko ^a   Kodama, Toshio ^a   Iida, Tetsuya ^a   Honda, Takeshi ^a   Oishi, Kazunori ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Molecular syringe; Type III secretion system; Vibrio parahaemolyticus

Indexed keywords

VIRULENCE FACTOR;

ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; GENE LOCUS; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; TYPE III SECRETION SYSTEM; VIBRIO PARAHAEMOLYTICUS;

BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; BACTERIAL VACCINES; CELLS, CULTURED; CLONING, MOLECULAR; ESCHERICHIA COLI; GENETIC LOCI; HELA CELLS; HUMANS; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; VIBRIO INFECTIONS; VIBRIO PARAHAEMOLYTICUS;

ESCHERICHIA COLI K12; NEGIBACTERIA; VIBRIO PARAHAEMOLYTICUS;

EID: 84867866294     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.018     Document Type: Article

References (23)

1. Dietz G.P.H., Bahr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Molecular and Cellular Neuroscience 2004, 27:85-131.
2. Galan J.E., Wolf-Watz H. Protein delivery into eukaryotic cells by type III secretion machines. Nature 2006, 444:567-573.
3. Izore T., Job V., Dessen A. Biogenesis, regulation, and targeting of the type III secretion system. Structure 2011, 19:603-612.
4. Konjufca V., Wanda S.Y., Jenkins M.C., Curtiss R. A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge. Infection and immunity 2006, 74:6785-6796.
5. Panthel K., Meinel K.M., Sevil Domenech V.E., Trulzsch K., Russmann H. Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors. International journal of medical microbiology: IJMM 2008, 298:99-103.
6. Chamekh M. Immunomodulation using genetically engineered bacteria for type III-mediated delivery of heterologous antigens and cytokines: potential application in vaccine and therapeutical developments. Immunopharmacology and immunotoxicology 2010, 32:1-4.
7. Makino K., Oshima K., Kurokawa K., Yokoyama K., Uda T., Tagomori K., Iijima Y., Najima M., Nakano M., Yamashita A., Kubota Y., Kimura S., Yasunaga T., Honda T., Shinagawa H., Hattori M., Iida T. Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae. Lancet 2003, 361:743-749.
8. Park K.S., Ono T., Rokuda M., Jang M.H., Okada K., Iida T., Honda T. Functional characterization of two type III secretion systems of Vibrio parahaemolyticus. Infection and immunity 2004, 72:6659-6665.
9. Ono T., Park K.S., Ueta M., Iida T., Honda T. Identification of proteins secreted via Vibrio parahaemolyticus type III secretion system 1. Infection and immunity 2006, 74:1032-1042.
10. Charpentier X., Oswald E. Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter. Journal of bacteriology 2004, 186:5486-5495.
11. Akeda Y., Okayama K., Kimura T., Dryselius R., Kodama T., Oishi K., Iida T., Honda T. Identification and characterization of a type III secretion-associated chaperone in the type III secretion system 1 of Vibrio parahaemolyticus. FEMS microbiology letters 2009, 296:18-25.
12. Hiyoshi H., Kodama T., Iida T., Honda T. Contribution of Vibrio parahaemolyticus virulence factors to cytotoxicity, enterotoxicity, and lethality in mice. Infection and immunity 2010, 78:1772-1780.
13. Okada N., Iida T., Park K.S., Goto N., Yasunaga T., Hiyoshi H., Matsuda S., Kodama T., Honda T. Identification and characterization of a novel type III secretion system in trh-positive Vibrio parahaemolyticus strain TH3996 reveal genetic lineage and diversity of pathogenic machinery beyond the species level. Infection and immunity 2009, 77:904-913.
14. Burdette D.L., Seemann J., Orth K. Vibrio VopQ induces PI3-kinase-independent autophagy and antagonizes phagocytosis. Molecular microbiology 2009, 73:639-649.
15. Yarbrough M.L., Li Y., Kinch L.N., Grishin N.V., Ball H.L., Orth K. AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling. Science 2009, 323:269-272.
16. Lee S.H., Galan J.E. Salmonella type III secretion-associated chaperones confer secretion-pathway specificity. Molecular microbiology 2004, 51:483-495.
17. Matsuda S., Okada N., Kodama T., Honda T., Iida T. A Cytotoxic type III secretion effector of Vibrio parahaemolyticus targets vacuolar H(+)-ATPase subunit c and ruptures host cell lysosomes. PLoS pathogens 2012, 8:e1002803.
18. Page A.L., Parsot C. Chaperones of the type III secretion pathway: jacks of all trades. Molecular microbiology 2002, 46:1-11.
19. Buttner D. Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria. Microbiology and molecular biology reviews: MMBR 2012, 76:262-310.
20. Hansen-Wester I., Chakravortty D., Hensel M. Functional transfer of Salmonella pathogenicity island 2 to Salmonella bongori and Escherichia coli. Infection and immunity 2004, 72:2879-2888.
21. Wilson J.W., Coleman C., Nickerson C.A. Cloning and transfer of the Salmonella pathogenicity island 2 type III secretion system for studies of a range of gram-negative genera. Applied and environmental microbiology 2007, 73:5911-5918.
22. Wilson J.W., Nickerson C.A. Cloning of a functional Salmonella SPI-1 type III secretion system and development of a method to create mutations and epitope fusions in the cloned genes. Journal of biotechnology 2006, 122:147-160.
23. Blanco-Toribio A., Muyldermans S., Frankel G., Fernandez L.A. Direct injection of functional single-domain antibodies from Escherichia coli into human cells. PloS one 2010, 5:e15227.